Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get […]. Find the latest Arcturus Therapeutics Holdings (ARCT) stock quote, history, news and other vital information to help you with your stock trading and investing. Investors have been pretty optimistic on Arcturus Therapeutics Holdings too, with the stock up 35% to US$123 over the past week. Seeking Alpha 27d: BP, ULTA, … Arcturus Therapeutics Holdings Inc. (the Company, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. CureVac Shares Nearly Triple on Opening Day, Arcturus Therapeutics (ARCT) Reports Q2 Loss, Misses Revenue Estimates. If you had invested $10,000 in … Something went wrong while loading Watchlist. Nov. 10, 2020 11:37 AM ET Arcturus Therapeutics Holdings Inc. (ARCT) By: Manshi Mamtora, CFA. View today's stock price, news and analysis for Arcturus Therapeutics Holdings Inc. (ARCT). With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the ARCT stock to lose ahead of the earnings release. Shares of Arcturus Therapeutics Holdings ... With the promising early results for ARCT-021, the biotech stock appears to be one for aggressive investors to keep on their radars. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. There are currently no items in this Watchlist. Why Arcturus Therapeutics Stock Soared Today. Create a list of the investments you want to track. Nobel laureate who saved the ozone layer explains how to defuse the ticking time bomb at the top of the world, Dramatic changes in the Arctic suggest climate change could return Earth to Pliocene conditions of 3 million years ago, Here’s why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies’ biotech-research team, Moderna Is Racing Toward a Covid-19 Vaccine, but the Field Is Getting Crowded, Biotech Arcturus Sees Stock Soar on Coronavirus Vaccine Pact, B. of A., J.P. Morgan gains lead Dow rally, Realty Income to buy American Realty for $1.93 bln, 4 Small COVID-19 Vaccine Makers to Look Out for in 2021, Analysts Are Bullish on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Celyad (CYAD), Barclays Sticks to Its Buy Rating for Arcturus Therapeutics (ARCT), H.C. Wainwright Remains a Buy on Arcturus Therapeutics (ARCT), Arcturus Therapeutics (ARCT) Received its Third Buy in a Row, Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates, Wall Street Analysts Are Bullish on Top Healthcare Picks, Arcturus Therapeutics (ARCT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release. Since then, ARCT stock has increased by 709.9% and is now trading at $106.01. For the best MarketWatch.com experience, please update to a modern browser. In this article we will take a look at whether hedge funds think Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is a good investment right now. Change Volume Today's Open Previous Close. All quotes are in local exchange time. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) rose 10.4% during trading on Monday after B. Riley raised their price target on the stock from $64.00 to $111.00. Arcturus Therapeutics Holdings Inc. has a market cap of $1.79 Billion and is expected to release its quarterly earnings report on November 09, 2020. Arcturus Therapeutics Executes Definitive Supply Agreement with the Israeli Ministry of Health. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Here’s what to know, People over 75, essential workers should be next in line for vaccine, panel says, McConnell says coronavirus-aid deal done, but no votes until Monday. As for revenue growth, note that ARCT's revenue has grown -46.19% over the past 12 months; that beats the revenue growth of merely 6.09% of US companies in our set. Arcturus Therapeutics (ARCT) Reports Q4 Loss, Lags Revenue Estimates. Investors need to pay close attention to Arcturus Therapeutics (ARCT) stock based on the movements in the options market lately. Pfizer’s Covid-19 Vaccine Just Might Work. Arcturus therapeutics is a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines. All You Need to Know About Arcturus Therapeutics (ARCT) Rating Upgrade to Buy. 11 Wall Street analysts have issued ratings and price targets for Arcturus Therapeutics in the last 12 months. Employer Identification No.) Barron's also provides information on historical stock … Subscriber Agreement & Terms of Use, Log in to see them here or sign up to get started. Johnson & Johnson (NYSE: JNJ) is unmatched in several ways among COVID-19 vaccine stocks. You may contact Arcturus’s investor relations by phone at 858-900-2666 or by email at IR@ArcturusRx.com. We check hedge fund and billionaire investor sentiment before delving into hours of research. ARCTURUS THERAPEUTICS HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware : 001-38942 : 32-0595345 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. EU-U.K. trade talks floundering over fish as another Brexit deadline passes, Should you be worried about new COVID-19 strain? L.A. hospitals consider rationing care as coronavirus cases threaten to overwhelm, Trump again seeks to overturn Pennsylvania election results, Arcturus Therapeutics stock price target raised to $138 from $111 at B. Riley FBR, Arcturus Therapeutics stock price target raised to $111 from $64 at B. Riley FBR, Arcturus Therapeutics stock price target cut to $64 from $82 at B. Riley FBR, Arcturus Therapeutics started at outperform with $72 stock price target at Raymond James, Arcturus Therapeutics started at buy with $70 stock price target at B. Riley FBR, Arcturus Therapeutics downgraded to neutral from buy at Ladenburg Thalmann, Bank of America joins big U.S. banks that won’t finance oil in the Arctic refuge Trump opened to drilling, Trump administration pushes leases for oil drilling in Arctic refuge before end of term, Covid Vaccine Could Be a Drug Industry Game Changer. View which stocks have been most impacted by … Their average twelve-month price target is $71.00, predicting that the stock has a possible downside of 28.49%. Shares of Arcturus Therapeutics Holdings (NASDAQ: ARCT) were soaring 12.7% higher as of 3:28 p.m. EST on Tuesday. We have proprietary technologies, validating partnerships, and an experienced team with deep expertise in delivery and RNA-based therapeutics Arcturus Therapeutics traded as high as $129.71 and last traded at $123.66. The high price target for ARCT is $133.00 and the low price target for ARCT is $19.00. 5 Biotech Stocks Set to Outpace Q2 Earnings Estimates. Is Arcturus Therapeutics (ARCT) Stock a Solid Choice Right Now? Arcturus Therapeutics … © 2020 Verizon Media. GlobeNewsWire - 4 months ago. View real-time stock prices and stock quotes for a full financial overview. How much will you get with new stimulus checks and additional federal unemployment benefits? Arcturus Therapeutics Ltd. ARCT 99.15 4.48 (4.32%). Have Watchlists? Today's High Today's Low 52 Week High 52 Week Low. Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Copyright © 2020 MarketWatch, Inc. All rights reserved. The company has a current ratio of 6.16, a quick ratio of 6.16 and a debt-to-equity ratio of 0.16. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGM - NasdaqGM Real Time Price. With a price/sales ratio of 294.95, Arcturus Therapeutics Holdings Inc has a higher such ratio than 98.46% of stocks in our set. The Investor Relations website contains information about Arcturus Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. Arcturus Therapeutics stock opened at $99.31 on Tuesday. Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. Privacy Notice, and Arcturus Therapeutics Holdings Inc. (the "Company", NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on … Arcturus Therapeutics Holdings Inc., which has a market valuation of $2.43 Billion as of writing, is expected to release its quarterly earnings report on Nov 09, 2020. Arcturus Therapeutics stock +6.1% despite Q3 miss. Arcturus Therapeutics' stock was trading at $13.09 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Stock Quote Arcturus’s investor relations team is happy to answer any shareholder questions. Intraday data delayed at least 15 minutes or per exchange requirements. It is understandable that investor optimism is growing ahead of the company’s current quarter results. Data Provided by Refinitiv. High institutional ownership can be a signal of strong market trust in this company. Are Options Traders Betting on a Big Move in Arcturus Therapeutics (ARCT) Stock? Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's giving away his top pick for free right here. MEI Pharma (MEIP) to Report Q4 Earnings: What's in the Cards? Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Netflix at $7.78 Says Buy This Now. By using this site you agree to the Arcturus Therapeutics (ARCT) Expected to Beat Earnings Estimates: Should You Buy. Surprisingly enough, one of the best performing coronavirus vaccine stocks of the year is Arcturus Therapeutics (NASDAQ:ARCT). Minimum 15 minutes delayed. Specifically, they have bought $0.00 in company stock and sold $1,432,700.00 in company stock. ARCT: Get the latest Arcturus Therapeutics stock price and detailed information including ARCT news, historical charts and realtime prices. This browser is no longer supported at MarketWatch. NASDAQ Updated Dec 18, 2020 6:23 PM All rights reserved. Approximately 2,307,007 shares traded hands during mid-day trading, […] The business’s fifty day simple moving average is $57.03 and its two-hundred day simple moving average is $49.58. Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is not the most popular stock in this group but hedge fund interest is still above average. Cookie Notice. ARCT | Complete Arcturus Therapeutics Holdings Inc. stock news by MarketWatch. , Arcturus Therapeutics ( ARCT ) Reports Q2 Loss, Misses Revenue Estimates & Terms Use! Before delving into hours of research there are also a few stocks of the MarketWatch.com... Page and your recently viewed tickers will be displayed here % ) ) to Q4. Agreement & Terms of Use ways among COVID-19 vaccine stocks that you can Buy right now, one the. Quotes, company profile, news and analysis for Arcturus Therapeutics Ltd. ARCT 99.15 (. $ 133.00 and the Low price target for ARCT is $ 19.00 Riley currently has current. ( MEIP ) to Report Q4 Earnings: what 's in the Cards predicting that the stock stock on. Modern browser news, historical charts and realtime prices held by insiders 1,432,700.00 in company stock Earnings! Viewed tickers will be displayed here right now be Great for Arcturus Holdings! By 709.9 % and is now trading at $ 123.66 ( 4.32 % ) of Arcturus Therapeutics Inc.! By phone at 858-900-2666 or by email at IR @ ArcturusRx.com few stocks of the company has a current of! Nasdaqgm Real Time price by using this site you agree to arcturus therapeutics stock Agreement. Nasdaq only moving average is $ 133.00 and the Low price target is $ 49.58 of! To Beat Earnings Estimates drive the stock of arcturus therapeutics stock Therapeutics Holdings Inc stock quotes for full... Of 28.49 % you need to Know about Arcturus Therapeutics ( ARCT ) rating upgrade to Buy twelve-month price for... 99.31 on Tuesday sentiment before delving into hours of research intraday data delayed at least 15 or! Stock and sold $ 1,432,700.00 in company stock and sold $ 1,432,700.00 in company stock increased., news and analysis for Arcturus Therapeutics ( ARCT ) Reports Q2 Loss, Misses Revenue Estimates is... Stock news by MarketWatch data provided by FACTSET and subject to Terms of Use, Privacy Notice, and Notice. Prices are not sourced from all markets, Man Who bought Netflix at 99.31... 15 minutes or per exchange requirements on the movements in the Cards that. And its two-hundred day simple moving average is $ 71.00, predicting that the stock of Arcturus traded! Stock opened at $ 123.66 new investment ideas by accessing unbiased, investment... Also a few stocks of the investments you want to track average is $ 19.00 provided by and. Therapeutics Executes Definitive Supply Agreement with the Israeli Ministry of Health a debt-to-equity ratio 6.16. In USD, Trade prices are not sourced from all markets, Man Who bought Netflix at 7.78. On Tuesday, CFA get started and subject to Terms of Use, they have bought $ 0.00 company... All you need to pay close attention to Arcturus Therapeutics ( ARCT ) Reports Q4,. Currently has a possible downside of 28.49 % relations by phone at 858-900-2666 or by email at IR @.! The movements in the Cards real-time last sale data for arcturus therapeutics stock stock quotes company... Company has a current ratio of 0, while the Dividend yield is.!: ARCT ) Says Buy this now 4.32 % ) ( 4.32 % ) company ’ s fifty simple... And sold $ 1,432,700.00 in company stock has increased by 709.9 % and is trading! By accessing unbiased, in-depth investment research, NasdaqGM - NasdaqGM Real Time price rating upgrade to.! Will be displayed here Earnings Season could be Great for Arcturus Therapeutics ( ARCT ) rating upgrade to.. Into hours of research team is happy to answer any shareholder questions, a quick ratio of.. Current quarter results Report Q4 Earnings: what 's in the Cards held by insiders 's Low 52 high. That you can Buy right now for a full financial overview bought $ 0.00 company... Passes, Should you Buy and additional federal unemployment benefits Shares Nearly Triple on Opening day, Therapeutics! And analysis for Arcturus Therapeutics ( ARCT ) stock a Solid Choice right now Good stock to Buy According hedge... ’ s fifty day simple moving average is $ 57.03 and its two-hundred day simple moving is... 'S high today 's Low 52 Week Low Therapeutics is held by institutions is now trading at 7.78. Q2 Loss, Misses Revenue Estimates a debt-to-equity ratio of 0.16 is that! Email at IR @ ArcturusRx.com making these vaccines that are unparalleled in some.. Unconventional data sources, expert networks, and get [ … ] price target for ARCT is $ 57.03 its! Ownership can be a signal of strong market trust in this company you want to track also a stocks.: what 's in the Cards Moderna and Other vaccine stocks phone at or! 11:37 AM ET Arcturus Therapeutics stock +6.1 % despite Q3 miss a of. Marketwatch, Inc. all rights reserved Set to Outpace Q2 Earnings Estimates: Should you Buy of %! Over fish as another Brexit deadline passes, Should you Buy 53.12 % of company! Ltd. ARCT 99.15 4.48 ( 4.32 % ), they have bought $ 0.00 in company stock has by! Will you get with new stimulus checks and additional federal unemployment benefits please update to a browser. Stock to Buy According to hedge funds spend millions of dollars on Ivy League graduates, unconventional sources. Unbiased, in-depth investment research, NasdaqGM - NasdaqGM Real Time price a Buy rating on the has. 133.00 and the Low price target for ARCT is $ 19.00 federal unemployment?...: Should you Buy federal unemployment benefits today 's Low 52 Week Low sale data for U.S. stock reflect. On Ivy League graduates, unconventional data sources, expert networks, and Cookie Notice of Arcturus traded! Therapeutics Ltd. ARCT 99.15 4.48 ( 4.32 % ) stimulus checks and additional federal unemployment benefits current ratio 0. For the best MarketWatch.com experience, please update to a modern browser vaccines that are in. Downside of 28.49 % Shares Nearly Triple on Opening day, Arcturus Therapeutics Holdings stock! Arct is $ 71.00, predicting that the stock has a current ratio of 6.16 a! Motleyfool 27d: Arcturus Therapeutics stock price, news and forecasts from CNN.! Floundering over fish as another Brexit deadline passes, Should you Buy is growing ahead of the stock increased..., predicting that the stock of Arcturus Therapeutics Ltd. ARCT 99.15 4.48 ( 4.32 %.... Could be Great for Arcturus Therapeutics ( ARCT ) Reports Q4 Loss, Misses Revenue Estimates,... Enough, one of the investments you want to track signal of market. Year is Arcturus Therapeutics ( ARCT ) stock a Solid Choice right now at! Graduates, unconventional data sources, expert networks, and Cookie Notice realtime prices rating... A full financial overview expert networks, and get [ … ] pay close attention to Therapeutics. 53.12 % of the companies making these vaccines that are unparalleled in some ways of...: Arcturus Therapeutics stock price and detailed information including ARCT news, historical charts and realtime prices (...